MedTrace Logo

Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients

NCT03899389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-04-04

No results posted yet for this study

Summary

The primary aim of the current research project is to determine whether the TMAO concentration in the blood can serve as a prognostic indicator of myocardial infarction.

The hypothesis is that in patients with recent myocardial infarction, TMAO concentration in blood is higher than in patients undergoing scheduled coronarography.

Conditions

  • Coronary Disease

Interventions

DIAGNOSTIC_TEST

plasma samples collection

Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples

Sponsors & Collaborators

  • Gdansk University of Physical Education and Sport

    lead OTHER

Principal Investigators

  • Robert A Olek, PhD · University of Physical Education and Sport in Gdansk

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03899389 on ClinicalTrials.gov